Barclays »

Vistagen Therapeutics Ord shares owned by Barclays

Quarter-by-quarter ownership of Vistagen Therapeutics Ord (VTGN) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Vistagen Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Vistagen Therapeutics Ord held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vistagen Therapeutics Ord by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $119k 23k 5.16

More positions owned by Barclays

Invesco Qqq Tr Opt Call Option (QQQ)
SPDR S&ampP 500 ETF TR Opt Put Option (SPY)
Microsoft Corp Opt Call Option (MSFT)
Ishares Tr Opt Call Option (IWM)
Apple (AAPL)
Amazon Opt Call Option (AMZN)
Alphabet Opt Put Option (GOOGL)
NVIDIA Corporation (NVDA)
Tesla Opt Put Option (TSLA)
Meta Platforms Opt Put Option (META)
Ishares Tr Fund (HYG)
Alphabet Opt Call Option (GOOG)
Visa Opt Put Option (V)
Broadcom (AVGO)
Berkshire Hathaway (BRK.B)

View all positions for Barclays

Top funds holding Vistagen Therapeutics Ord

BVF
Dr. Jeffrey R. Jay, M.D.
Vanguard Group
Nantahala Capital Management
Commodore Capital
Citadel Advisors
Sphera Funds Management
Susquehanna International
ADAR1 Capital Management
Two Sigma Investments
Goldman Sachs Group
BML Capital Management
Bank Of Montreal
Gts Securities
William Blair $ Company

View all funds holding Vistagen Therapeutics Ord